Bristol-Myers is too, if you listen to the DNDN cultists. The Dr. Kwon who’s running the Ipilimumab study at the Mayo Clinic that generated the recent publicity is part of the cabal of hedge funds and hired hands who exist to take down DNDN. They know this because Kwon spoke out against the protocol of DNDN’s IMPACT trial in some article in Forbes.
Oh, wait a minute, that wasn’t Dr. Kwon, it was Dr. Wang. Well, that’s close enough—they both work for competitors and they’re both Asian.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.